Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE
Life on a Blood Thinner: Insights and Advice from an Anticoagulant Specialist - YouTube
The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology
Treatment Considerations | XARELTO® (rivaroxaban) HCP
NOAC Dose-Adjustment Recommendations in Renal Impairment and AF | Download Table
Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events | AAFP
Xarelto® - Dosing Guide
Dosing - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Target-Specific Oral Anticoagulants
Xarelto® rivaroxaban Prescriber Guide
MANAGEMENT OF ANTICOAGULATION FOR ATRIAL FIBRILLATION 2014 - ppt download
XARELTO® for PE | XARELTO® (rivaroxaban)
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar
البورد العراقي للصيدلة السريرية - ✓Anticoagulants for Atrial Fibrillation Dabigatran; Rivaroxaban; Apixaban; Edoxaban ✓Classification Anticoagulant 💊 Dabigatran (Pradaxa): direct thrombin inhibitor 💊Rivaroxaban (Xarelto): direct factor Xa inhibitor ...
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology
CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many chronic indications, most commonly VTE treatment/prophylaxis, atrial fibrillation, and valvular heart disease. VTE & AF can both be treated with either warfarin
Safety Profile - NVAF | XARELTO® (rivaroxaban) HCP
Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse
Xarelto® - Dosing Guide
Dosing & Treatment Information | XARELTO® (rivaroxaban) HCP
Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Direct Oral Anticoagulants are High-Risk Medications with Potentially Complex Dosing | PSNet
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect
Pediatric VTE | XARELTO® (rivaroxaban) HCP
